Uluslararası VI. Alzheimer Hastalığı ve İlişkili Bozukluklar Ortadoğu temalı Kongre, İstanbul’da 25-27 Ekimde yapılacaktır. İlginize kongre duyurusunu ve ön kongre programını sunuyoruz. – TürkPsikiyatri|
We are pleased to announce the Sixth International Conference on Alzheimer’s Disease and Related Disorders in the Middle East! Alzheimer’s disease and related illnesses have received relatively little attention in the region of the Middle East, an area with a population of over 225 million people. The progressive aging of Middle Eastern populations supports the importance of dementia studies in the region.
In April 2001, a meeting endorsed by the World Federation of Neurology, Alzheimer’s Disease International and the Pancyprian Association of Alzheimer’s Disease was held in Cyprus to bring together workers concerned with the medical and social aspects of dementia. Based upon the success of that first conference, four additional installments of this conference have been convened in the region. Participants have included physicians and scientists from across the Middle East, Europe, United States and other countries around the globe. In each of these conferences plenary lectures were presented by world-renowned experts in Alzheimer’s disease and related disorders. Other presentations covered all aspects of dementia, mild cognitive impairment and related illnesses, including diagnosis, treatment, pathophysiology, pathology, genetics, epidemiology, and health economics. Recent results from clinical trials in Alzheimer’s disease were presented, with consideration of the possibilities for extending availability of clinical trials to Middle East populations.
We believe that we need to ensure a continuity of such meetings in the Middle East, in order to demonstrate our common aim to conquer Alzheimer’s disease and related disorders as well as our solidarity as scientists and physicians across borders, ethnicity, religion and gender. With our Sixth International Conference on Alzheimer’s Disease and Related Disorders in the Middle East, we hope to ensure this continuity and build upon the successes of our previous five editions. With our two days of sessions, we will be bringing together, once more, a distinguished group of speakers, allowing more opportunities to learn together, network, collaborate and raise awareness of dementia, Alzheimer’s disease and related disorders in the region.
We hope you will consider joining us and look forward to welcoming you to the conference in October.
Changiz Geula, Ph.D.
Marwan Sabbagh, M.D.
Robert Friedland, M.D.
Murat Emre, M.D.
Clinical Course of Alzheimer’s Disease: The Egyptian Experience
Nasser Loza, MD, Medical Director
Behman Hospital, Cairo, Egypt
Copper, cholesterol and Cognition in Jordan
Eman Al-Khateeb, MBChB, MSc (UCLA), PhD, Professor of Neurophysiology
Faculty of Medicine, University of Jordan, Amman, Jordan
Illiteracy, Cognition and Dementia: A Challenge in Dementia Research in Middle East
Maryam Noroozian, MD, Associate Professor of Neurology
Tehran University of Medical Sciences, Tehran, Iran
Conversion from MCI to AD in an Arabic elderly population in Israel
Rivka Inzelberg, PhD, Professor of Neuroscience
The Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer, Israel
Parkinson’s Disease Dementia
Murat Emre, MD, Professor of Neurology, Director Behavioral Neurology and Movement Disorders Unit
Faculty of Medicine, Istanbul University, Istanbul, Turkey
Atrial Fibrillation Predicts Cognitive Impairment in Patients with Ischemic Stroke
Eliyahu H. Mizrahi, M.D., Clinical Lecturer
Sackler Faculty for Medicine, Tel Aviv University, Tel Aviv, Israel
Healthy brain aging and the multiple reserve hypothesis
Robert Friedland, MD, Professor, Department of Neurology
University of Louisville, Louisville, Kentucky, USA
Structural Basis of Amyloid Toxicity: from Biophysics to Therapeutic Strategies
Hilal Lashuel, PhD, Associate Professor of Neuroscience
Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
Association of Methylene Tetra Hydro Folate Reductase 677T Gene Polymorphisms and
Susceptibility to Alzheimer’s Disease in the Egyptian Population
Doaa Hewedi, PhD, Assistant Professor of Psychiatry and Geriatric Psychiatry Consultant, Ain Shams University, Cairo – Egypt
Common Pathogenic Mechanisms of Down Syndrome and Alzheimer’s Disease
Ahmad Salehi, M.D. Ph.D. Clinical Associate Professor
Department of Psychiatry & Behavioral Sciences Stanford Medical School, Stanford, California, USA
Cognitive Super Aging: Anatomic and Pathologic Correlates
Changiz Geula, PhD, Professor of Neuroscience
Cognitive Neurology and Alzheimer’s Disease Center Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA
TREM2 mutations: A new Risk Factor for Sporadic Alzheimer’s Disease and a New Genetic Cause for
Familial Frontotemporal Lobar Degeneration
Hakan Gurwit, MD, Professor of Neurology
Behavioral Neurology and Movement Disorders Unit Faculty of Medicine, Istanbul University, Istanbul, Turkey
Alzheimer’s Disease Treatment – Where Have We Been, Where Are We Going?
Diana Paleacu Kertesz, MD, Lecturer
Department of Neurology at Sackler School of Medicine, Tel Aviv University, Israel
Research Advances in Diagnostics and Therapeutics in Alzheimer’s Disease
Marwan Sabbagh, MD, Research Professor of Neurology
University of Arizona College of Medicine, Phoenix, Arizona, USA
An Alzheimer Center in an Emerging Country: Concept and Usefulness
Riadh Gouider, MD, President of Pan Arab Union of Neurological Societies, Head of Department of Neurology
Razi Hospital La Manouba, Tunis, Tunisia
Establishing Alzheimer’s Associations in the Middle East
Diane Mansour, President
Alzheimer’s Association Lebanon, Beirut, Lebanon